Absent contraindications, optimal medical therapy for heart failure with preserved ejection fraction (HFpEF) should include a ...
Findings from a new report by the American Heart Association (AHA) suggest that Ultromics' EchoGo Heart Failure artificial ...
Finerenone Lowers Blood Pressure in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
Finerenone produced sustained reductions in systolic BP and consistently reduced cardiovascular death and heart failure ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Starting a statin may improve outcomes in patients with heart failure with preserved ejection fraction (HFpEF) who are initially free from atherosclerotic cardiovascular disease (ASCVD), according to ...
Phenotyping in HFpEF aids in tailoring therapies, addressing comorbidities, and improving patient outcomes. Artificial intelligence models effectively diagnose HFpEF and predict mortality, enhancing ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Jennifer E. Ho, MD ...
Mavacamten, a drug initially developed to treat hypertrophic cardiomyopathy, has shown signs of reducing heart stress in patients with heart failure with preserved ejection fraction. Heart failure ...
Serial KCCQ-TSS decline emerged as the most prominent pre-event signal for sudden death, contrasting with improving symptoms and biomarkers among survivors over the same interval. Trajectories before ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results